Basic Materials / Specialty ChemicalsKSE
$2885.00
-55.00 (-1.88%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 19%
FCF escenarios
weak_data · normalized FCF $-20.6B · quality 51.0/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
47/100
C
Piotroski
5/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$184.4B
P/E
9.2x
↓EV/EBITDA
4.5x
↓ROE
4.8%
↑Gross Margin
12.5%
↓Debt/Equity
0.38
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+6.1%
FCF CAGR
—
FCF margin
-7.4%
FCF / Net income
-1.14x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $279.82B · net income $18.18B · FCF $-20.64B
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $279.82B | $279.82B | $286.85B | $271.10B | $234.56B |
| Net Income | $18.18B | $18.18B | $15.32B | $36.12B | $24.46B |
| EBITDA | $46.45B | $46.45B | $45.30B | $63.80B | $46.65B |
| EPS | 313.05 | 313.05 | 265.85 | 650.18 | 435.38 |
| Gross Margin | 12.5% | 12.5% | 12.7% | 13.0% | 14.2% |
| Operating Margin | 2.1% | 2.1% | 1.7% | 1.3% | 2.2% |
| Net Margin | 6.5% | 6.5% | 5.3% | 13.3% | 10.4% |
| Balance Sheet | |||||
| Debt/Equity | 0.38 | 0.38 | 0.31 | 0.29 | 0.26 |
| Current Ratio | 1.42 | 1.42 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $-20.64B | $-20.64B | $-3.14B | $-41.51B | $-11.35B |
| Returns | |||||
| ROE | 4.8% | 4.8% | 4.1% | 10.1% | 7.3% |
| Valuation | |||||
| P/E | 9.22 | 9.22 | 11.66 | 4.83 | 6.81 |
| EV/EBITDA | 4.47 | 4.47 | 4.43 | 3.90 | 4.70 |
| P/B | 0.45 | 0.45 | 0.48 | 0.49 | 0.50 |
| Growth & Yield | |||||
| Revenue Growth | -2.5% | -2.5% | 5.8% | 15.6% | — |
| EPS Growth | 17.8% | 17.8% | -59.1% | 49.3% | — |
| Dividend Yield | 6.7% | 6.7% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
-6.5%
EPS terminal req.
$256.00
Spread vs growth
24.2%
5Y implied EPS CAGR
-0.2%
EPS terminal req.
$309.75
Spread vs growth
18.0%
10Y implied EPS CAGR
4.8%
EPS terminal req.
$498.86
Spread vs growth
13.0%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+1.6%
Start / end P/E
11.4x → 9.2x
EPS bridge
265.85 → 313.05
Residual
-3.4%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.